Pharmacokinetic (PK) - pharmacodynamic (PD) study of gemcitabine (G) in a randomised phase II trial of carboplatin (C) combined with G at standard rate infusion or fixed dose rate infusion in patients with advanced non-small-cell lung cancer (NSCLC).

被引：0
|
作者：
Soo, RA
Lim, HL
Wang, LZ
Tham, LS
Soong, R
Lee, HS
Liang, S
Lee, SC
Boyer, M
Goh, BC
机构：
[1] Natl Univ Singapore Hosp, Singapore 117548, Singapore
[2] Natl Univ Singapore, Singapore 117548, Singapore
[3] Clin Trials & Epidemiol Res Unit, Singapore, Singapore
[4] Sydney Canc Ctr, Sydney, NSW, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：141S / 141S
页数：1
相关论文
共 50 条
  • [1] A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer
    Soo, R. A.
    Wang, L. Z.
    Tham, L. S.
    Yong, W. P.
    Boyer, M.
    Lim, H. L.
    Lee, H. S.
    Millward, M.
    Liang, S.
    Beale, P.
    Lee, S. C.
    Goh, B. C.
    ANNALS OF ONCOLOGY, 2006, 17 (07) : 1128 - 1133
  • [2] GEMCITABINE (G) AT FIXED DOSE RATE (FDR) INFUSION, COMBINED WITH CISPLATIN (C), IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC). A PHASE II STUDY WITH INCREMENTAL G DOSES
    Caffo, Orazio
    Santo, Antonio
    Binato, Samuela
    Zucchetti, Massimo
    Centonze, Maurizio
    Lucenti, Antonio
    Giovannini, Monica
    d'Incalci, Maurizio
    Cartei, Giuseppe
    Cetto, Gianluigi
    Galligioni, Enzo
    ANNALS OF ONCOLOGY, 2004, 15 : 30 - 30
  • [3] Non conventional suboptimal doses of gemcitabine (G) at fixed dose rate (FOR) infusion, combined with cisplatin (C), in patients with advanced non-small cell lung cancer (NSCLC).
    Caffo, O
    Santo, A
    Binato, S
    Zucchetti, M
    Lucenti, A
    Centonze, M
    Giovannini, M
    D'Incalci, M
    Cartei, G
    Galligioni, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 699S - 699S
  • [4] Fixed-dose rate infusion and standard rate infusion of gemcitabine in patients with advanced non-small-cell lung cancer: a meta-analysis of six trials
    Qiu, Man-Tang
    Ding, Xiang-Xiang
    Hu, Jing-Wen
    Tian, Hong-Ya
    Yin, Rong
    Xu, Lin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (06) : 861 - 873
  • [5] Fixed-dose rate infusion and standard rate infusion of gemcitabine in patients with advanced non-small-cell lung cancer: a meta-analysis of six trials
    Man-Tang Qiu
    Xiang-Xiang Ding
    Jing-Wen Hu
    Hong-Ya Tian
    Rong Yin
    Lin Xu
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 861 - 873
  • [6] Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer
    Orazio Caffo
    Stefania Fallani
    Elena Marangon
    Stefania Nobili
    Maria Iris Cassetta
    Viviana Murgia
    Federica Sala
    Andrea Novelli
    Enrico Mini
    Massimo Zucchetti
    Enzo Galligioni
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 1197 - 1202
  • [7] Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer
    Caffo, Orazio
    Fallani, Stefania
    Marangon, Elena
    Nobili, Stefania
    Cassetta, Maria Iris
    Murgia, Viviana
    Sala, Federica
    Novelli, Andrea
    Mini, Enrico
    Zucchetti, Massimo
    Galligioni, Enzo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (06) : 1197 - 1202
  • [8] Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma
    J. De Castro
    A. Lorenzo
    S. Morales
    J. Belón
    J. Dorta
    J. Lizón
    C. Madroñal
    P. M. Gallurt
    E. Casado
    J. Feliu
    M. González Barón
    Cancer Chemotherapy and Pharmacology, 2005, 55 : 197 - 202
  • [9] Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma
    De Castro, J
    Lorenzo, A
    Morales, S
    Belón, J
    Dorta, J
    Lizón, J
    Madroñal, C
    Gallurt, PM
    Casado, E
    Feliu, J
    Barón, MG
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (02) : 197 - 202
  • [10] Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer
    Wang, Lin Run
    Huang, Ming Zhu
    Zhang, Guo Bing
    Xu, Nong
    Wu, Xiu Hua
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (04) : 601 - 607
12345